Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/cspharmaceuticals.com/httpdocs/wp-includes/functions.php on line 6121
News Archive - Page 2 of 2 - CS Pharmaceuticals Limited

新闻

November 14, 2024 CS Pharmaceuticals Announces China Patent Grant
October 24, 2024 CS Pharmaceuticals announces appointment of Professor Bruce Robinson as Non Executive Director
February 20, 2024 CS Pharmaceuticals Announces Japan patent granted
September 20, 2023 CS Pharmaceuticals Announces US patent granted
July 28, 2023 创盛桥康收购 AxeroVision Inc. 及其治疗睑板腺功能障碍引起的干眼症药物研 发项目
下载新闻稿
January 31, 2023 创盛桥康宣布获得大熊制药公司 Bersiporocin 在中国的商业化权利独家许可
下载新闻稿
October 11, 2022 创盛桥康宣布就 Ripple Therapeutics 的 IBE-814 产品，达成中国市场商业化 独家许可协议
下载新闻稿
June 1, 2022 创盛桥康宣布任命 John Dawson CBE 为非执行董事
下载新闻稿
February 15, 2022 创盛桥康宣布从 Pharmaxis 取得 BRONCHITOL®在中国的独家商业化权利
下载新闻稿
December 12, 2021 创盛桥康宣布与灼见医药达成战略合作协议，共同构建罕见病数字平台
下载新闻稿
November 29, 2021 创盛桥康宣布委任 Roberto Lee 为非执行董事
下载新闻稿
November 22, 2021 创盛桥康宣布获得 Downing Ventures 的战略投资
下载新闻稿
September 13, 2021 创盛桥康宣布设立上海全资子公司，以期提高公司的药政和临床能力
下载新闻稿
June 22, 2021 Darren Mercer 宣布任命 Andrew Wilks 教授为非执行董事
下载新闻稿
June 1, 2021 创盛桥康宣布任命 Darren Mercer 为首席执行官
下载新闻稿
June 1, 2021 创盛桥康启动专注于中国市场的特药业务
下载新闻稿